Aktiesnakken — Februar 2010
-
hmm - US ned med ca 3 pct i dag. Det lover ikke godt for i morgen
-
det er ikke bare uzynligmab?
-
vi har brug for champagnen'
-
skal vi regne i chatten?
-
det er en ren kasskracka
-
vi får jo altid leveret stoffet tilbage gratis
-
hvis solsen har ret i sit regnestykke, bliver det her en blockbuster
-
bare i CLL
-
spørgsmålet er blot om det kan være blevet modtaget så godt? Husk på ved forrige ash....der mente lægerne at arzerra var "super charged"
-
rituxiamab
-
vi leget bare lidt hya
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind